Defining Functional Correction Thresholds in Primary Ciliary Dyskinesia for Effective Gene Therapies

Area of Science:

• Cell Biology
• Respiratory Medicine
• Genetics

Background:

• Primary ciliary dyskinesia (PCD) is a genetic disorder affecting motile cilia function and mucociliary clearance.
• Mutations in CCDC40 lead to defective cilia, impacting airway health.
• The functional impact of mixed populations of normal and mutant cilia in PCD is not well understood.

Purpose of the Study:

• To investigate how mixtures of CCDC40-deficient and wild-type ciliated cells affect mucociliary transport.
• To establish a functional threshold for therapeutic intervention in PCD.

Main Methods:

• Human bronchial epithelial cells with varying CCDC40 deficiency ratios were differentiated to model heterogeneous epithelia.
• High-speed video microscopy and particle-tracking analyzed ciliary motion and mucus transport.
• Electron microscopy assessed cilia ultrastructure.

Main Results:

• CCDC40-deficient cells exhibited ultrastructural defects, including abnormal centrioles and absent dynein arms.
• Mucociliary transport decreased nonlinearly with increasing CCDC40-deficient cell ratios.
• Transport efficiency plateaued when approximately 75% of ciliated cells were wild-type.

Conclusions:

• A functional correction threshold for PCD was defined.
• Effective gene therapies must overcome the negative impact of mutant epithelial cells.
• These findings offer a quantitative benchmark for guiding PCD gene therapy development.